1. Home
  2. LGO vs ELTX Comparison

LGO vs ELTX Comparison

Compare LGO & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Largo Inc.

LGO

Largo Inc.

N/A

Current Price

$0.20

Market Cap

49.1M

Sector

N/A

ML Signal

N/A

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

N/A

Current Price

$1.50

Market Cap

45.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LGO
ELTX
Founded
1988
2011
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.1M
45.6M
IPO Year
2007
2014

Fundamental Metrics

Financial Performance
Metric
LGO
ELTX
Price
$0.20
$1.50
Analyst Decision
Buy
Buy
Analyst Count
2
3
Target Price
$1.45
★ $13.00
AVG Volume (30 Days)
★ 683.0K
299.5K
Earning Date
11-17-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 39.29
EPS
★ N/A
N/A
Revenue
N/A
★ $2,301,000.00
Revenue This Year
$17.41
N/A
Revenue Next Year
$36.00
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.20
$1.25
52 Week High
$1.93
$16.00

Technical Indicators

Market Signals
Indicator
LGO
ELTX
Relative Strength Index (RSI) 16.22 40.87
Support Level N/A $1.35
Resistance Level $0.37 $1.98
Average True Range (ATR) 0.03 0.20
MACD -0.01 0.01
Stochastic Oscillator 1.18 36.36

Price Performance

Historical Comparison
LGO
ELTX

About LGO Largo Inc.

Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Share on Social Networks: